Adrenaline or UK 14304 (a specific a2-adrenoceptor agonist) and phorbol ester (phorbol 12,13-dibutyrate; PdBu) or bioactive diacylglycerols (sn-1,2-dioctanoylglycerol; DiC8) synergistically induced platelet aggregation and ATP secretion. The effect on aggregation was more pronounced than the effect on secretion, and it was observed in aspirinized, platelet-rich plasma or suspensions of washed aspirinized platelets containing ADP scavengers. No prior shape change was found. In the presence of adrenaline, DiC8 induced reversible aggregation and PdBu evoked irreversible aggregation that correlated with the different kinetics of DiC8-and PdBu-induced protein kinase C activation. Adrenaline and UK 14304 did not induce or enhance phosphorylation induced by DiC8 or PdBu of myosin light chain (20 kDa), the substrate of protein kinase C (47 kDa), or a 38 kDa protein. Immunoprecipitation studies using a G, .mona antiserum or a G1a antiserum showed that Gia is not phosphorylated after exposure of platelets to PdBu or PdBu plus adrenaline. Adrenaline, PdBu or adrenaline plus PdBu did not cause stimulation of phospholipase C as reflected in production of [32P]phosphatidic acid. Adrenaline caused a small increase of Ca2" in the platelet cytosol of platelets loaded with Indo-1; this effect was also observed in the absence of extracellular Ca2". However, under conditions of maximal aggregation induced by adrenaline plus PdBu, no increase of cytosolic Ca2" was observed. Platelet aggregation induced by PdBu plus adrenaline was not inhibited by a high intracellular concentration of the calcium chelator Quin-2. These experiments indicate that a2-adrenoceptor agonists, known to interact with Gi, and protein kinase C activators synergistically induced platelet aggregation through a novel mechanism. The synergism occurs distally to Gi protein activation and protein kinase C-dependent protein phosphorylation and does not involve phospholipase C activation or Ca2+ mobilization.
INTRODUCTION
Adrenaline has direct effects on platelets that are not mediated by ADP, endoperoxides or thromboxane A2 liberated from platelets [1] [2] [3] . It induces primary platelet aggregation [1] [2] [3] [4] , potentiation of stimulus-induced aggregation and secretion [4] [5] [6] [7] [8] and inhibition of adenylate cyclase through activation of a2-adrenergic receptors [9, 10] . a2-Adrenoceptors in platelets are known to be coupled to the guanine-nucleotide-binding protein G., which mediates inhibition of adenylate cyclase [11, 12] . Inhibition of adenylate cyclase is not, however, the mechanism by which adrenaline induces and potentiates aggregation because (a) in platelet-rich plasma, adrenaline-induced primary aggregation is associated with an increase rather than a decrease of cyclic AMP levels [13] ; (b) adrenaline [4] [5] [6] [7] [8] , but not a direct inhibitor of adenylate cyclase (2',5'-dideoxyadenosine) [14] , potentiates stimulus-induced aggregation and secretion; and (c) various classes of ac2-adrenoceptor agonists can be distinguished that either induce and potentiate platelet aggregation or inhibit adenylate cyclase, or do both [15, 16] .
Under conditions in which adrenaline induces primary aggregation, no activation ofphospholipase C is observed [17] . In addition, adrenaline does not seem to activate protein kinase C [18] or to increase Ca2+ in the platelet cytosol [19, 20] . Thus the effector mechanism by which a2-adrenoceptor activation causes and potentiates platelet aggregation is unknown. Phorbol esters and bioactive diacylglycerols share some properties of adrenaline: they do not induce the typical shape change response in the aggregometer [21] , and do not activate phospholipase C [22, 23] or increase Ca2`in the platelet cytosol [24] . In contrast to a2-adrenoceptor agonists, they do activate protein kinase C [25] . Although maximal activation of protein kinase C does not necessarily cause platelet aggregation and secretion, protein kinase C activation can synergize with Ca2+ mobilization to induce platelet responses [23, 26] . On the other hand, protein kinase C can cause a desensitization of receptormediated platelet responses [27] [28] [29] [30] .
We recently observed that phorbol ester added to platelet-rich plasma sensitized platelets to activation by various physiological agonists and that the sensitizing effect of phorbol ester on platelet aggregation induced by adrenaline was unique among several platelet agonists studied [31] . The present study was developed to inAbbreviations used: PdBu, phorbol 12,13-dibutyrate; DiC8, sn-1,2-dioctanoylglycerol; OAG, l-oleoyl-2-acetylglycerol; G1 
Labelling of platelets with 32P
Platelet-rich plasma (40-50 ml) was obtained from 110 ml of human blood anticoagulated with 1 vol. of 3.80% (w/v) trisodium citrate. Prostacyclin (PGI2) (20 ng/ml) was added, and platelets were pelleted by centrifugation for 10 min at 800 g. Platelets were resuspended in 2 ml of a phosphate-free buffer (pH 7.35) containing NaCl (138 mM), KCI (2.9 mM), Hepes (20 mM), MgCl2,6H20 (1 mM), EGTA (1 mM) and glucose (5 mM). Aspirin (1 mM), apyrase (0.8 units of ADPase/ ml) and PGI2 (500 ng/ml) were added, and platelets were incubated with 4-5 mCi of 32P at 37 IC for 90 min. In other experiments, labelling of platelets with 32p was performed as described [31, 33] , with essentially similar results obtained. At the end of the incubation, 10 ml of prewarmed (37 IC) buffer containing apyrase and PGI2 was added, and platelets were pelleted by centrifugation for 10 min at 800 g. Platelets were resuspended in 10 ml of the buffer (37 IC) as described above but containing CaCl2 (0.1 mM) instead of EGTA. Apyrase (0.6 units of ADPase/ml) or, in experiments in which ATP secretion was measured, phosphocreatine (2 mM) and creatine kinase (20 units [30] . 32P-Labelled proteins were separated on SDS/polyacrylamide (11 %) gels using a Tris buffer with a pH of 8.8. Specific zones of the dried gels localized by autoradiography were cut out and measured for 32p radioactivity by liquid scintillation counting [32] . The experiments shown are representative of at least four others.
Pertussis toxin-dependent ADP-ribosylation of platelet Gi Platelet-rich plasma (40-50 ml) from 110 ml of blood was incubated with 1 mM-aspirin for 15 min at 37°C and, after addition of PGI2 (50 ng/ml), was centrifuged. The platelet pellet was washed in 20 ml of buffer containing 1 mM-EGTA and apyrase (0.6 units of ADPase/ml), centrifuged (after addition of PGI2) and resuspended in 10 ml of buffer without apyrase or EGTA. Samples (1.3 ml) of platelet suspension were incubated for 2 min at 37°C without stirring in aggregometer cuvettes under continuous recording of light transmission. Aliquots (0.2 ml) of platelet suspensions before (controls) and at various times after exposure to adrenaline, PdBu or a combination of both were transferred to 0.05 ml of the ADP-ribosylation mixture.
The ADP-ribosylation mixture was freshly prepared and contained (final concentrations in the platelet suspension) EDTA (1 mM), pertussis toxin (7 ,g/ml), NAD (100/,M), [32P]NAD (30 1ItCi/ml), NADP (1 mM), GTP (100 gM), saponin (100 /tg/ml), thymidine (10 mM) and ATP (1 mM) (see also ref. [35] ). The pertussis toxin was preactivated in 1 mM-dithiothreitol at 37°C for 30 min. Pertussis toxin-dependent ADP-ribosylation of the platelet lysate was carried out for 1 h at 37 'C. After addition of EDTA (10 mM), the platelet membranes were pelleted by centrifugation (13000 g for 5 min) and resuspended in 0.1 ml of sample buffer. 32P-labelled ADP-ribosylated Gia subunits were separated on SDS/polyacrylamide (11 o ) gels and quantified as described above. The experiment shown is representative of ten others.
Immunoprecipitation of Gjx from platelets
Immunoprecipitation of Gia was carried out according to the methods described in refs. [36] and [37] . Two antisera were used: the specific antiserum (AS7), which was produced in rabbits against the C-terminal decapeptide of rod transducin, and recognizes Gia subunits, and the antiserum A569, which was produced in rabbits against the pentadecapeptide GAGES-GKSTIVKQMK that is located near the N-terminal region and recognizes all G. subunits.
1989 378 a2-Adrenoceptors and protein kinase C 32P-Labelled ADP-ribosylated platelet membranes dissolved in water (0.2ml) or 32P-prelabelled platelet suspensions (0.2 ml; exposed to adrenaline, PdBu or both) were solubilized with 0.2 ml of buffer (pH 7.2) containing 1 %0 SDS, aprotinin (20 ,ig/ml), 0.4 mMNaVO4. 2 mM-dithiothreitol, 150 mM-NaCl and 50 mMNa2HPO4, and then they were heated for 1 min at 90 'C.
Then, 40 ,l of 1Ox RIPA (10 % deoxycholate, 100
Triton X-100, 150 mM-NaCl and 50 mM-Na2HPO4) was added to the clear extract and incubated with 4,1 of normal rabbit serum ('control') for 45 min on ice. Protein A-Sepharose (12 mg in 150,u of RIPA) or Protein A (extracellular)-Agarose (1 mg in 100,tl of RIPA) was added and incubated for 30 min on ice. After centrifugation in a microfuge for 5 min, the supernatant (550 Sl) was incubated at 4 'C with 3 4dl of antiserum AS7 or 4 ,ul of affinity-purified A569 for 2 h, and then with Protein A-Sepharose or Protein A-Agarose for 1 h. After centrifugation, the supernatant was discarded, and Protein A-Sepharose or Protein A-Agarose of both control and antiserum-incubated samples was washed four times with 1 ml of RIPA buffer and once with phosphate-buffered saline. The samples were resuspended in 100 ,ul of sample buffer and heated for 3 min at 100 'C, and the supernatant was separated by SDS/polyacrylamide (11 %)-gel electrophoresis. Proteins were stained with silver nitrate and dried gels were exposed to X-OMAT films at -80 'C (during 2-5 days) for autoradiography. The experiments shown are representative of four others.
Measurement of Ca21 mobilization
Platelet-rich plasma from 160 ml of freshly drawn blood anticoagulated with trisodium citrate (0.38 Qo, w/v) was incubated with 5 /LM-Indo-1/AM (dissolved in dimethyl sulphoxide) and I ,tM-prostaglandin E1 for 45 min at 37 'C. Then aspirin (1 mM) was added and incubation was continued for a further 15 min. Platelets were pelleted by centrifugation and resuspended in 30 ml of buffer containing apyrase (0.6 units of ADPase/ml) and 0.01 mM-CaCl2. Ca2" measurements were performed in 1 ml aliquots of platelet suspension which had been prewarmed to 37 'C for 2 min. Fluorescence (F) was recorded using a Perkin-Elmer 512 double-beam fluorescence spectrophotometer with the emission wavelength set to 390 nm and the excitation wavelength set to 340 nm. F, Fma.x' Fmin and 'Ceak were recorded, and the intracellular Ca2" concentrations were calculated as described in refs. [38] and [39] . The experiments shown are representative of five others.
RESULTS
Synergism of x2-adrenoceptor agonists and phorbol ester in inducing platelet aggregation and secretion Adrenaline added before, with or after PdBu profoundly potentiated the rate and extent of aggregation of washed platelets (Fig. 1) and platelet-rich plasma [31] .
This synergism was independent of the formation of endoperoxides/thromboxane A2 or the release of ADP, since it was observed in aspirinized platelets containing ADP scavengers (phosphocreatine/creatine kinase or apyrase). In the presence of adrenaline, DiC8 induced a reversible aggregation response, whereas aggregation induced by PdBu was irreversible (Fig. 1) . Aspirinized, 32P-prelabelled, washed platelets were resuspended in buffer containing apyrase (0.6 units of ADPase/ml) and samples (0.6 ml) were exposed to DiC8 (added in ethanol, final concentration 1 %) or PdBu with or without adrenaline (Adr.). Aggregation was measured using a single channel aggregometer adjusted to maximal sensitivity. Note that the initial upward deflection of the pen after addition of the agonists is due to dilution of the platelet suspension with the solvent of the agonist solution.
PdBu on protein phosphorylation in platelets. Protein kinase C activation induced by DiC8 was reversible; protein kinase C activation evoked by PdBu was irreversible (Figs. 2 and 3) .
The synergistic effect of PdBu plus adrenaline on platelet aggregation was dependent on the concentration of both PdBu and adrenaline; 12-O-tetradecanoyl phorbol 13-acetate (TPA) was similarly effective, whereas the inactive parent compound 4a-phorbol was ineffective [31] . The preincubation time of platelets with PdBu did not affect its synergism with adrenaline on platelet aggregation; it could be extended up to 12 min without observing a decrease of the potentiation of aggregation [31] . Platelets were preincubated up to 3 min with adrenaline before addition of PdBu, and the synergistic action of both agonists on platelet aggregation was not decreased (results not shown). The action of adrenaline was imitated by the synthetic a2-adrenoceptor agonist UK 14304 (Table 1) .
The synergism of Pd3Bu and adrenaline on ATP secretion was quantitatively much less pronounced and only observed at higher phorbol ester concentrations ( Table 1) . Secretion of ATP started later than aggregation. PdBu, adrenaline or the simultaneous addition of both agonists did not induce shape change (Fig. 1 PdBu plus adrenaline had no effect (Table 2 ). In contrast, platelets treated with thrombin (0.1 unit/ml) showed a 50 % decrease of pertussis-toxin-dependent ADPribosylation of Gi.
To support the hypothesis that the potentiating effect of adrenaline on platelet aggregation is mediated through Vol. 263 Gi, we used guanabenz, which is a weak a.2-adrenoceptor agonist for the aggregatory response but does not cause inhibition of adenylate cyclase [15, 16] . Therefore, guanabenz does not interact with Gia [11] . Guanabenz (10-100 uM) added with PdBu or OAG to aspirinized platelets did not show synergistic action on platelet aggregation (results not shown).
Absence of phospholipase C activation and Ca2l mobilization under conditions of maximal aggregation induced by adrenaline plus PdBu The synergistic action of PdBu plus adrenaline on platelet aggregation was evident under conditions of virtual absence of extracellular Ca2+ (< 100 nM). Fig. 3 ; Table 1 ; results not shown). Therefore, maximal platelet aggregation induced by adrenaline plus PdBu could occur without phospholipase C activation and Ca2+ mobilization.
Loading platelets with high concentrations of Quin-2 (4-5 mM) that created a Ca21 sink in the platelet cytosol and delayed vasopressin (100 nM)-and ionophore A23 187 (1 5 /M)-induced platelet shape change and aggregation of platelet-rich plasma did not inhibit aggregation induced by PdBu or PdBu plus adrenaline (results not Table 2 . Effects of adrenaline and PdBu on pertussis toxin-dependent ADP-ribosylation of G, Intact platelets were exposed for the times indicated to adrenaline, PdBu, or both, and pertussis toxin-dependent ADPribosylation was measured after platelet lysis with saponin as detailed in the Experimental section. [42] .
Adrenaline neither increased the binding of PdBu to platelets [43] nor potentiated PdBu-induced protein kinase C activation. This-may be explained by the failure of adrenaline to increase cytosolic Ca2" to a significant level and to produce 1,2-diacylglycerol; both molecules are involved in the translocation of protein kinase C to the membrane [44] . Thus, a2-adrenoceptor agonists synergize with protein kinase C by a mechanism that is clearly different from that observed with other platelet stimuli such as vasopressin, ADP, platelet-activating factor and prostaglandin endoperoxide analogues, which activate phospholipase C, increase Ca2" in the cytosol and enhance PdBu binding to platelets [43] . These stimuli potentiate phorbol ester-induced protein kinase C activation, whereas adrenaline shows true synergism with protein kinase C at a step distal to the enzyme.
Phorbol esters and bioactive diacylglycerols have some properties in common with adrenaline: they do not induce the typical shape change from discoid to spheroid platelets; they evoke a small aggregation response; and they do not induce phospholipase C activation or an increase of Ca2" in the platelet cytosol [19] [20] [21] [22] [23] [24] . Our . However, we found that adrenaline, in contrast to thrombin, did not reduce pertussis toxindependent ADP ribosylation of G. This might be explained by a 20-to 100-fold excess of G. proteins over a2-adrenergic receptors in platelets [45] . a2-Adrenergic receptors may be coupled to fewer G, molecules than thrombin receptors or, alternatively, the thrombininduced decrease of pertussis toxin-dependent ADPribosylation of G, may be caused by factors other than receptor-induced dissociation of G. In support for the latter, we observed that the Ca21 ionophore A23187 also reduced pertussis toxin-dependent ADP-ribosylation of Gi proteins in platelets (W. Siess & E. G. Lapetina, unpublished work). Our results, showing functional synergism with the full Lz2-adrenoceptor agonist UK 14304 but no synergism with the partial a2-agonist guanabenz, which does not inhibit adenylate cyclase, indicate that G, dissociation might be involved. Inhibition of adenylate cyclase is certainly not the mechanism by which adrenaline synergizes with phorbol esters in inducing platelet aggregation (see Introduction). In support of this fact, phorbol esters do not potentiate but rather attenuate the adrenaline-induced decrease of cyclic AMP levels in platelets exposed to prostaglandin E, [46] . G,a could possibly produce actions in platelets other than inhibition of adenylate cyclase. The possibility that Gpa released from fl/y after adrenaline could be phosphorylated by protein kinase C [40] was investigated in the present study. We found that exposure of intact platelets to phorbol ester alone increased the phosphorylation of a protein that comigrated with Gia on SDS gels and was also present in immunoprecipitates obtained after incubating platelet lysates with antiserum against Gia or GcOmmona. However, our results also show that this protein, which is phosphorylated by protein kinase C, is not identical to G,a. It seems that this phosphorylated protein, as well as other phosphorylated platelet proteins, binds directly to the Protein A-Sepharose or Protein A-Agarose that was used to precipitate the immunocomplexes.
Our study shows that the target of the synergism of adrenaline plus phorbol ester must be distal to Gi and protein kinase C. Although the messenger system of a2-adrenoceptor action in platelets is unknown, one could suggest that it involves an ion channel corresponding to recent studies that link Gi activation to K+ channels in cardiac tissue [47, 48] . Also, a2-adrenergic receptors in neuronal tissues seem to be linked via a pertussis toxinsensitive Gi protein to K+ channels [49] . On 
